Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
Holding ACRS?
Track your performance easily

Aclaris Therapeutics (ACRS) Financial Statements

578 Followers

Aclaris Therapeutics Financial Overview

Aclaris Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.826; its P/E ratio is -1.42; Aclaris Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.77M$ 2.40M$ 17.57M$ 9.28M$ 994.00K
Gross Profit$ 2.14M$ 1.59M$ 11.14M$ 8.43M$ 2.42M
EBIT$ -10.99M$ -15.91M$ -23.72M$ -14.57M$ -28.47M
EBITDA$ -10.74M$ -15.67M$ -23.49M$ -14.35M$ -28.25M
Net Income Common Stockholders$ -10.99M$ -16.94M$ -1.49M$ -14.57M$ -29.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 111.09M$ 128.17M$ 119.11M$ 103.05M$ 119.78M
Total Assets$ 161.07M$ 174.06M$ 197.41M$ 218.35M$ 235.65M
Total Debt$ 0.00$ 0.00$ 426.00K$ 310.00K$ 458.00K
Net Debt$ -111.09M$ -128.17M$ -118.68M$ -102.74M$ -119.32M
Total Liabilities$ 27.25M$ 32.05M$ 40.23M$ 62.02M$ 55.90M
Stockholders Equity$ 133.84M$ 142.01M$ 157.18M$ 156.33M$ 179.79M
Cash Flow-
Free Cash Flow$ -12.31M$ -20.95M$ -7.20M$ -26.94M$ -19.39M
Operating Cash Flow$ -12.32M$ -20.82M$ -6.76M$ -26.86M$ -19.15M
Investing Cash Flow$ -674.00K$ 16.83M$ 7.55M$ 34.83M$ -21.16M
Financing Cash Flow$ -11.00K$ -55.00K$ 49.00K$ -87.00K$ 26.74M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History

Aclaris Therapeutics Debt to Assets

Aclaris Therapeutics Cash Flow

Aclaris Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis